Overview  | Interim Roundtables  | Publications  | Online Resources


The Vaccines Policy Lab highlights resources and links to leading organizations working on vaccines and immunization, with a focus on international policy and resources, R&D, finance, and advocacy and communication. Challenges to keeping individuals healthy come from many directions, and vaccines are some of the most cost effective and impactful tools for preventing disease and improving global health outcomes. The cost of leaving these challenges unattended is great, but the opportunities to create a positive turning point in health are exponentially greater. The Vaccines Policy Lab aims to provide tools to help vaccine developers and advocates make strides in creating a healthier global community.

2011 Summit Interim Roundtables

Brainstorming discussions convened in key regional locations to discuss how the 2011 Summit could effectively engage leaders around the theme of vaccines. The meetings brought together a small group of key, multi-sector stakeholders and implementers to share perspectives, and highlight successes and innovation in the field. Meetings were by invitation only.

Roundtables convened:

  • May 2010: Seattle, USA
  • June 2010: London, UK
  • September 2010: Tokyo, Japan
  • November 2010: London, UK
  • November 2010: Washington, DC
  • January 2011: New Delhi, India
  • February 2011: Beijing, China


  • Perspectives from Industry: Tiered Pricing and Vaccine Access
    What are the key challenges to improving access to vaccines in the 21st century? Pharmaceutical leaders Mark Feinberg (Merck Vaccines at Merck & Co.), Suresh Jadhav (Serum Institute of India Ltd.), and Jean Stéphenne (GSK Biologicals) provide industry perspectives on the increasingly complex nature of vaccine development and the need for a revised tiered pricing structure that better addresses the needs of low- and middle-income countries.
  • Vaccines: Harnessing Opportunity in the 21st Century
    2011 Pacific Health Summit conference report, “Vaccines: Harnessing Opportunity in the 21st Century," which summarizes key discussions and impact of the 2011 Summit.
  • Preparing for the Global Market: China’s Expanding Role as a Vaccine Manufacturer
    What are the forces behind China’s recent enormous growth in vaccine manufacturing, and what are the implications for global health? A novel gathering of Chinese industry and government leaders discussed the outward-facing trends of the booming industry and its latest efforts to meet international regulatory standards. This discussion originally took place at a workshop of the 2011 Pacific Health Summit on vaccines.
  • Keeping the Trust: Targeting Communication Gaps and Driving Vaccine Confidence
    This report sprang from a captivating 2011 Summit plenary on the different ways to promote public confidence in, and curb outbreaks of anxiety surrounding, immunization efforts. Foremost leaders in global health contribute to a holistic discussion on an array of topics, including open communication between scientists and journalists, and channels to effectively navigate social and cultural misunderstandings.
  • Thailand’s New National Vaccine Strategy: Building Capacity, Accelerating Production
    Following the 2011 Pacific Health Summit on vaccines, NBR spoke with Yot Teerawattananon (Thailand’s Health Intervention and Technology Assessment Program) about Thailand’s new national vaccine strategy. Dr. Teerawattananon discusses Thailand’s vaccine infrastructure, potential challenges to the plan, and the role of middle-income countries in vaccine manufacturing.
  • Calls for Collaboration
    This collection of Calls for Collaboration, distributed at the 2011 Pacific Health Summit, represents one of the ways the Secretariat responded to the vision for what could be accomplished together at the Summit, and beyond. It is our hope that they will continue to inspire dialogue and foster new partnerships in vaccines and immunization.
  • 2011 Summit Challenge
    Global leaders shared their vision for the 2011 Pacific Health Summit. The Challenge contains brief thought pieces addressing the 2011 Summit theme - "Vaccines: Harnessing Opportunity in the 21st Century."
  • The Current Vaccine Wave and Global Health: Production, Policy, Pricing, and Promising Technologies
    Adel Mahmoud (Princeton University) discusses the major trends and achievements in the vaccine field over the last two decades, focusing on the impact of, and challenges surrounding, new vaccines, including pricing policies, financial structures, and the role of emerging market manufacturers.
  • Delivering on the Promise of Vaccines: Strengthening the Continuum from R&D to Delivery to Eradication
    In this Impact & Innovations series thought piece, Dr. Seth Berkley posits that the path for vaccines, from R&D, to delivery and eradication of disease, has historically been long and bumpy, and that the full life-saving potential of vaccines will only be realized if these efforts are better integrated into a seamless continuum.
  • A Pivotal Moment for China and Vaccine Manufacturing
    Jiankang (Jack) Zhang (PATH, China Office), a key leader in China's vaccine industry, explains that the March 2011 announcement of China achieving WHO “pre-qualification” for its national regulatory system for vaccines, which will allow Chinese-manufactured vaccines to compete for UN tenders, marks a turning point for China's vaccine industry and international engagement.
  • Immunization Effectiveness: The Less Understood Dimensions
    Is vaccine effectiveness only dependent upon the quality of the vaccine and cold chain reliability, or more a broad result of how well health systems deliver? Dr. KV Balasubramaniam explores critical aspects of vaccine delivery, including health system preparedness, capacity, and ‘program errors,’ arguing that much more attention and resources should be devoted to improving delivery systems to ensure the full benefits of vaccination reach those who need it most.
  • Maximizing Every Dose and Dollar: The Imperative of Efficiency in Vaccine Delivery
    Are health delivery systems in developing countries prepared to accommodate the demands and stresses that the new generation of bulkier, more expensive vaccines will bring over next decade? This Oliver Sabot, Prashant Yadav, and Michel Zaffran thought piece argues that seemingly simple and well-run vaccine supply chain and delivery systems are, in reality, quite complex and ill-prepared to handle soon-to-be-available vaccines, and that these systems will need systematic overhauls to deliver on the life-saving potential of these innovations.
  • In Defense of Health, Beyond Humanitarianism: Marketing Vaccines as National Security Products
    Dr. Najwa Khuri-Bulos explores how the global health community should be branding and marketing vaccines, and the potential to improve uptake and increase country-driven funding for vaccines by learning from the success of military marketing and branding.
  • Expanding Vaccine Manufacturing Capacity and Potential: Broad Evolutions in Technology
    In advance of the 2011 Summit, NBR, the Summit Secretariat, conducted a series of interviews on current issues facing the global vaccines and immunization field. We spoke with Dr. Nigel Darby (GE Healthcare), who explained that technologies for vaccine development and manufacturing are rapidly expanding and adapting to address the major diseases and emerging threats of today; an increase in-country manufacturing capacity is helping fuel this transformation.

Online Resources

  • History of Vaccines Timeline
    From the earliest known practice of inoculation by the Chinese in 1000 AD, to the recent India-manufactured Meningitis A vaccines introduced in Africa, the History of Vaccines Timeline covers the breadth of fascinating developments and discoveries in the human battle to prevent infectious disease. The timeline was assembled for the 2011 Summit on vaccines in partnership with the College of Physicians of Philadelphia.
  • Vaccines Resource Page
    An online vaccines resource page, which provides an archive of information and international resources on issues pertaining to vaccines, with links to important organizational and literature websites, reports, evolving developments, and ongoing initiatives.
  • Pandemic Influenza Vaccines Resource
    A comprehensive resource for those interested in the history and evolving developments in pandemic influenza vaccines, which provides background research, international policy resources, and key organizations. Additionally, a report of key findings from a pandemic influenza workshop in January 2007 in Beijing, co-presented by The NBR Center for Health and Aging and Chinese CDC, can be found here. The workshop goal was to improve the global environment for avian influenza vaccine research, development manufacturing, regulation, and dissemination, and by doing so create a platform for global collaboration on vaccines.
Back to Top